Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the most undervalued small-cap stocks to buy according to analysts.

Patients with vs without MetS were associated with an increased risk for late-stage knee OA and more severe pain during early-stage disease.

Participants who screened positive for sarcopenia were linked to greater risks for radiographic and symptomatic knee OA progression and TKR.

Now, rising to the challenge, an Arizona State University team of researchers has built a powerful new AI tool, called Ark +, ...